These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15167059)

  • 81. Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy.
    Asano J; Suzuki Y; Yajima S; Inoue K; Shimozawa N; Kondo N; Murase M; Orii T
    Brain Dev; 1994; 16(6):454-8. PubMed ID: 7694994
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [X-linked adrenoleukodystrophy with an atypical radiological pattern].
    Ulate-Campos A; Petanas-Argemi J; Rebollo-Polo M; Jou C; Sierra C; Armstrong J; Fons-Estupina MC
    Rev Neurol; 2018 Apr; 66(7):237-240. PubMed ID: 29557549
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Adrenoleukodystrophy in a Chinese boy.
    Wong V
    Brain Dev; 1992 Jul; 14(4):276-7. PubMed ID: 1279999
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Glycerol trioleate/glycerol trierucate therapy in X-linked adrenoleukodystrophy: saturated and unsaturated fatty acids in blood cells. Implications for the follow-up.
    Ruiz M; Pampols T; Girós M
    J Inherit Metab Dis; 1996; 19(2):188-92. PubMed ID: 8739962
    [No Abstract]   [Full Text] [Related]  

  • 85. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
    Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
    Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The clinical course of childhood and adolescent adrenoleukodystrophy before and after Lorenzo's oil.
    Suzuki Y; Imamura A; Shimozawa N; Kondo N
    Brain Dev; 2001 Mar; 23(1):30-3. PubMed ID: 11226726
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy.
    Crowther MA; Barr RD; Kelton J; Whelan D; Greenwald M
    Am J Hematol; 1995 Feb; 48(2):132-3. PubMed ID: 7847331
    [No Abstract]   [Full Text] [Related]  

  • 88. X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.
    van Geel BM; Assies J; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):4-14. PubMed ID: 9221959
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical aspects and adrenal functions in eleven Japanese children with X-linked adrenoleukodystrophy.
    Miyoshi Y; Sakai N; Hamada Y; Tachibana M; Hasegawa Y; Kiyohara Y; Yamada H; Murakami M; Kondou H; Kimura-Ohba S; Mine J; Sato T; Kamio N; Ueda H; Suzuki Y; Shiomi M; Ohta H; Shimozawa N; Ozono K
    Endocr J; 2010; 57(11):965-72. PubMed ID: 20859061
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cerebral X-linked adrenoleukodystrophy in a girl with Xq27-Ter deletion.
    Hershkovitz E; Narkis G; Shorer Z; Moser AB; Watkins PA; Moser HW; Manor E
    Ann Neurol; 2002 Aug; 52(2):234-7. PubMed ID: 12210797
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope.
    Moser HW
    Ann Neurol; 1993 Aug; 34(2):121-2. PubMed ID: 8338333
    [No Abstract]   [Full Text] [Related]  

  • 92. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy.
    Kruse B; Barker PB; van Zijl PC; Duyn JH; Moonen CT; Moser HW
    Ann Neurol; 1994 Oct; 36(4):595-608. PubMed ID: 7944292
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Proceedings of the 4th International Workshop of the Adrenoleukodystrophy International Research Group (ALD-IRG), University of York, 3 September 1998.
    Alger S; Green A; Köhler W; Sokolowski P; Moser H
    J Inherit Metab Dis; 2000 Jul; 23(5):449-52. PubMed ID: 10947198
    [No Abstract]   [Full Text] [Related]  

  • 94. X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES.
    Furlan FLS; Lemes MA; Suguimatsu LCF; Pires CTF; Santos MLSF
    Rev Paul Pediatr; 2019; 37(4):465-471. PubMed ID: 31241695
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intra familial phenotypical variations in adrenoleukodystrophy.
    Gosalakkal J; Balky AP
    Neurol India; 2010; 58(1):109-11. PubMed ID: 20228476
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy.
    Musolino PL; Rapalino O; Caruso P; Caviness VS; Eichler FS
    Brain; 2012 Sep; 135(Pt 9):2676-83. PubMed ID: 22961546
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.
    Loes DJ; Stillman AE; Hite S; Shapiro E; Lockman L; Latchaw RE; Moser H; Krivit W
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1767-71. PubMed ID: 7847226
    [TBL] [Abstract][Full Text] [Related]  

  • 98. MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines.
    Mallack EJ; Turk BR; Yan H; Price C; Demetres M; Moser AB; Becker C; Hollandsworth K; Adang L; Vanderver A; Van Haren K; Ruzhnikov M; Kurtzberg J; Maegawa G; Orchard PJ; Lund TC; Raymond GV; Regelmann M; Orsini JJ; Seeger E; Kemp S; Eichler F; Fatemi A
    J Inherit Metab Dis; 2021 May; 44(3):728-739. PubMed ID: 33373467
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A child with reading impairment and a family history of adrenoleukodystrophy.
    Kotagal S; Geller TJ; Wall D; Lastra C
    Semin Pediatr Neurol; 1999 Sep; 6(3):233-6; discussion 236-7. PubMed ID: 10522346
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.
    Zierz S; Schröder R; Unkrig CJ
    Clin Investig; 1993 Oct; 71(10):802-5. PubMed ID: 8305837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.